Press release
Increased Incidence of Chronic Conditions Instrumental for Global Non-alcoholic Steatohepatitis (NASH) Biomarker Market Growth
Non-alcoholic Steatohepatitis (NASH) Biomarker Market
"Browse 49 Market Data Tables and 42 Figures spread over 167 Pages, along with an in-depth TOC on the Global Non-alcoholic Steatohepatitis (NASH) Biomarker Market Forecast 2021-2028."
Non-alcoholic steatohepatitis (NASH) is characterized by a destructive form of non-alcoholic fatty liver disease (NAFLD). The condition often progresses to more severe disorders, including cirrhosis and hepatocellular carcinoma. As a result, NASH is likely to even surpass the hepatitis C virus infection, thereby becoming the leading cause of liver transplantation, worldwide, over the upcoming decade.
REQUEST CUSTOMIZATION LINK - https://inkwoodresearch.com/request-for-custom-report/?utm_source=paidpr&utm_medium=inkwood&utm_campaign=openpr
Rising Prevalence of Chronic Diseases to Drive Market Growth
Non-alcoholic fatty liver disease (NAFLD) is a significant factor accredited to the rising incidence of liver disease, across the globe. NAFLD entails extra fat in individuals' liver, who consume less or no alcohol. Besides, obesity and insulin resistance are among the condition's major causes.
On the other hand, the prevalence of alcoholic fatty liver and liver cancer cases is rapidly growing, as the number of alcoholics increase, annually. Likewise, the incidence of hepatocellular carcinoma is estimated to be 50 million, worldwide, while more than 15 million people in the United States are diagnosed with alcoholic fatty liver. Hence, the therapeutic choices available for liver cancer and alcoholic fatty liver, play an essential role in treating such diseases.
REQUEST FREE SAMPLE LINK - https://inkwoodresearch.com/reports/non-alcoholic-steatohepatitis-biomarker-market/?utm_source=paidpr&utm_medium=inkwood&utm_campaign=openpr
Pharma & CRO Industry is the Leading End-User
The pharma and contract research organizations (CROs) division is anticipated to display a lucrative growth rate, over the upcoming years. The strong growth is accredited to the increased demand for non-invasive NASH diagnostic and monitoring tools in the ongoing clinical trials, particularly by CROs as well as pharmaceutical manufacturers. In addition, numerous enterprises are involved in therapeutics investigations for NASH. However, factors such as unknown etiology, complex pathophysiology, and expensive treatment for NASH, are expected to limit the segment's revenue growth, over the forecast period. Besides, during the drug's clinical trial, the routine monitoring of drug therapy is ideally non-invasive. This factor is projected to bolster the adoption of biomarker tests, predominantly in terms of NASH diagnostics.
North America Dominated the Global Market in 2020
The growing incidence of obesity and diabetes, the projected launch of pipeline molecules, as well as the early diagnosis of NASH are accredited to North America's market growth. Moreover, favorable reimbursement policies within the region's healthcare infrastructure, coupled with the easy availability of innovative therapeutics, play an essential role in augmenting the market growth.
The competitive rivalry within the global market is expected to be moderate, on account of the unavailability of treatment. Key market players concentrate on partnerships and research and development, for introducing new products into the market.
Leading enterprises operating in the market include, Novartis AG, Pfizer Inc, Merck & Co, AstraZeneca, etc.
VIEW TABLE OF CONTENT LINK - https://inkwoodresearch.com/reports/non-alcoholic-steatohepatitis-biomarker-market/#table-of-contents?utm_source=paidpr&utm_medium=inkwood&utm_campaign=openpr
About Inkwood Research
Inkwood Research specializes in syndicated & customized research reports and consulting services. Market intelligence studies with relevant fact-based research are customized across industry verticals such as technology, automotive, chemicals, materials, healthcare, and energy, with an objective comprehension that acknowledges the business environments. Our geographical analysis comprises North & South America, CEE, CIS, Middle East, Europe, Asia, and Africa.
Contact Us
https://inkwoodresearch.com
sales@inkwoodresearch.com
+1 857-302-4704
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Increased Incidence of Chronic Conditions Instrumental for Global Non-alcoholic Steatohepatitis (NASH) Biomarker Market Growth here
News-ID: 2710213 • Views: …
More Releases from Inkwood Research
United States Wood Coatings Market Analysis 2024-2032
Inkwood Research states that the United States Wood Coatings Market is expected to achieve a compound annual growth rate (CAGR) of 5.02% during the forecast period of 2024-2032, with projected revenues reaching $xx million by 2032.
This growth is driven by a combination of factors, including increasing construction activities, rising consumer preference for aesthetically appealing wood products, and advancements in coating technologies.
Refer to the Report Summary Here: https://inkwoodresearch.com/reports/united-states-wood-coatings-market/?utm_source=PaidPRNew&utm_medium=OpenPR&utm_campaign=InkwoodPR
Prominent companies in the…
Rising Uptake of Industry 4.0 to Amp Motion Control Market Growth
As per a new market research report launched by Inkwood Research, the Global Motion Control Market is predicted to reach $26041.29 million by 2032, growing at a CAGR of 5.13% during the forecasting period, 2024-2032.
Refer to the Report Summary Here: https://inkwoodresearch.com/reports/global-motion-control-market-forecast-2024-2032/?utm_source=PaidPRNew&utm_medium=OpenPR&utm_campaign=InkwoodPR
This insightful market research report by Inkwood Research focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. The report covers all the aspects…
Rise in Golf Tourism to Elevate Golf Cart Market Growth
As per a new market research report launched by Inkwood Research, the Global Golf Cart Market is expected to grow at a CAGR of 5.68% during the forecasting period, 2024-2032.
Refer to the Report Summary Here: https://inkwoodresearch.com/reports/golf-cart-market/?utm_source=PaidPRNew&utm_medium=OpenPR&utm_campaign=InkwoodPR
This insightful market research report by Inkwood Research focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. The report covers all the aspects of this comprehensive market by…
Government Rules to Promote the Growth of the Electric Vehicle Power Inverter Ma …
As per a new market research report launched by Inkwood Research, the Global Electric Vehicle Power Inverter Market is expected to reach $34868.78 million by 2032, growing with a CAGR of 14.36% during the forecasting period, 2024-2032.
Refer to the Report Summary Here: https://inkwoodresearch.com/reports/electric-vehicle-power-inverter-market/?utm_source=PaidPRNew&utm_medium=OpenPR&utm_campaign=InkwoodPR
This insightful market research report by Inkwood Research focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. The report covers all…
More Releases for NASH
Nonalcoholic Steatohepatitis (NASH) Market Massive Growth opportunity Ahead
Introduction
Nonalcoholic Steatohepatitis (NASH) is an advanced form of nonalcoholic fatty liver disease (NAFLD) characterized by fat accumulation in the liver along with inflammation and liver cell damage. If left untreated, NASH can progress to fibrosis, cirrhosis, liver failure, or hepatocellular carcinoma. Closely tied to the global obesity and diabetes epidemic, NASH has become a major healthcare burden, with millions affected worldwide and no widely approved curative therapy to date.
The NASH…
Non-Alcoholic Steatohepatitis (NASH) - Drug Pipeline Landscape, 2023
Nonalcoholic steatohepatitis (NASH) is a type of fatty liver disease. It is characterized by the accumulation of fat in the liver, inflammation, and damage. NASH can lead to cirrhosis, liver failure, and death. The exact cause of NASH is unknown, but it is believed to be associated with obesity, insulin resistance, and diabetes. Treatment of NASH is focused on weight loss, exercise, and the control of diabetes and insulin resistance.
NASH…
Non Alcoholic Steatohepatitis (NASH) Market Size to Hit $21,879 Million by 2028 …
According to our experience research team, Non Alcoholic Steatohepatitis (NASH) Market was valued at USD 1,569 Million in 2021, and the global Non Alcoholic Steatohepatitis (NASH) industry is projected to reach a value of USD 21,879 Million by 2028, at a CAGR of 60.4% during the forecast period 2022-2028
The report is focused on gaining various Non Alcoholic Steatohepatitis (NASH) market trends, dynamics, growth drivers, opportunities, weaknesses, strengths, and threats restraining…
NASH Market Insight and Landscape report
Report Snapshot:
NASH is one of the furthermost causes of liver disease worldwide and will probably emerge as the leading cause of end-stage liver disease in the coming years, with the disease affecting both adults and children. The epidemiology and demographic characteristics of NASH vary across different country level. Furthermore, individuals with NAFLD have a high frequency of metabolic comorbidities and could place a growing strain on health-care systems from their…
Nash releases debut EP 'She Don't Know'
London-based singer/songwriter Nash has released his debut EP She Don’t Know. Recorded at the legendary RAK Studios, She Don’t Know has the feel of 60s rock but with a modern twist, leaving the listener hooked throughout and wanting to come back for another listen. She Don’t Know’s leading single CK is an infectious number which is sure to be a hit for 2017.
Listening to the Beatles and Jack White growing…
Nash Technologies at GITEX/GULFCOMMS 2010
Harvey Nash subsidiary presents expert services to telecom operators in the Middle East, Africa and South Asia region
Nürnberg/Germany, 10th September 2010 – For the first time Nash Technologies will be present at GITEX/GULFCOMMS, the largest international trade event for mobile, fixed, IP and satellite communications for the Middle East, Africa and South Asia region, in Dubai from 17th to 21st October 2010 offering its telecom expert services. Nash Technologies will…
